2021
DOI: 10.1016/j.msec.2021.112390
|View full text |Cite
|
Sign up to set email alerts
|

Injectable hydrogel loaded with paclitaxel and epirubicin to prevent postoperative recurrence and metastasis of breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
26
0
2

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(28 citation statements)
references
References 43 publications
0
26
0
2
Order By: Relevance
“…Self-healing injectable hydrogels are able to spatially confine therapeutics and release them locally in a sustained manner, thereby maximizing therapeutic effects and minimizing off-target side effects. The use of injectable hydrogels for delivery of chemotherapeutics or nanoparticles has been investigated for various types of cancer. Intratumoral administration of chemotherapeutics using a hydrogel matrix prolongs their therapeutic efficacy compared to free drug administration and allows sustained tumor growth suppression, as shown in Figure C.…”
Section: Applications Of Self-healing Injectable Hydrogels For Tissue...mentioning
confidence: 99%
“…Self-healing injectable hydrogels are able to spatially confine therapeutics and release them locally in a sustained manner, thereby maximizing therapeutic effects and minimizing off-target side effects. The use of injectable hydrogels for delivery of chemotherapeutics or nanoparticles has been investigated for various types of cancer. Intratumoral administration of chemotherapeutics using a hydrogel matrix prolongs their therapeutic efficacy compared to free drug administration and allows sustained tumor growth suppression, as shown in Figure C.…”
Section: Applications Of Self-healing Injectable Hydrogels For Tissue...mentioning
confidence: 99%
“…EPI is an anthracycline drug that has been widely used in the clinical treatment of NSCLC, breast, liver, and stomach cancer (10,11,13,23). EPI inhibits the proliferation of cells by embedding itself directly in the cell DNA, thus interfering with the transcription process, inhibiting mRNA synthesis and topoisomerase II activity, and producing oxygen and free radicals (10,12).…”
Section: Discussionmentioning
confidence: 99%
“…EPI is an anthracycline drug that has been widely used in the clinical treatment of NSCLC, breast, liver, and stomach cancer (10,11,13,23). EPI inhibits the proliferation of cells by embedding itself directly in the cell DNA, thus interfering with the transcription process, inhibiting mRNA synthesis and topoisomerase II activity, and producing oxygen and free radicals (10,12). As a traditional chemotherapy drug, EPI has a significant effect in the adjuvant treatment of early breast cancer, mainly by inhibiting the metastasis of breast cancer cells, thus improving the prognosis of patients with breast cancer (10,24).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations